Home/Filings/4/0001209191-14-011854
4//SEC Filing

CONCERT PHARMACEUTICALS, INC. 4

Accession 0001209191-14-011854

CIK 0001367920operating

Filed

Feb 18, 7:00 PM ET

Accepted

Feb 19, 4:51 PM ET

Size

5.5 KB

Accession

0001209191-14-011854

Insider Transaction Report

Form 4
Period: 2014-02-19
Daws D. Ryan
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2014-02-19+123,893123,893 total
    Exercise: $14.09Exp: 2024-02-19Common Stock (123,893 underlying)
Footnotes (1)
  • [F1]This option vests as to 25% of the original 123,893 shares on January 20, 2015 and vests as to an additonal 6.25% of the original shares at the end of each successive three-month period through and including January 20, 2019.

Issuer

CONCERT PHARMACEUTICALS, INC.

CIK 0001367920

Entity typeoperating

Related Parties

1
  • filerCIK 0001367920

Filing Metadata

Form type
4
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 4:51 PM ET
Size
5.5 KB